REDHILL BIOPHARMA LTD. Current Assets
REDHILL BIOPHARMA LTD. (RDHL) had Current Assets of $12.55 million as of 2025-06-30, per its 6-K filed 2025-09-05.
Financial Statements › Notes
ifrs-full:CurrentAssets · last filed 2025-09-05
- 2025-06-30: Current Assets $12.55M.
- 2024-12-31: Current Assets $11.91M.
- 2024-06-30: Current Assets $15.70M.
- 2023-12-31: Current Assets $16.14M.
| Period end | Current Assets |
|---|---|
| 2025-06-30 | $12.55M 6-K · filed 2025-09-05 |
| 2024-12-31 | $11.91M 6-K · filed 2025-09-05 |
| 2024-06-30 | $15.70M 6-K · filed 2024-08-29 |
| 2023-12-31 | $16.14M 20-F · filed 2025-04-10 |
| 2023-06-30 | $27.05M 6-K · filed 2023-08-17 |
| 2022-12-31 | $85.90M 20-F · filed 2024-04-08 |
| 2022-06-30 | $91.27M 6-K · filed 2022-11-07 |
| 2021-12-31 | $89.15M 20-F · filed 2023-04-28 |
| 2021-06-30 | $98.49M 6-K · filed 2021-08-26 |
| 2020-12-31 | $70.50M 20-F · filed 2022-03-17 |
| 2020-06-30 | $61.13M 6-K · filed 2020-08-13 |
| 2019-12-31 | $53.21M 20-F · filed 2021-03-18 |
| 2019-06-30 | $39.97M 6-K · filed 2019-07-23 |
| 2018-12-31 | $56.79M 20-F · filed 2020-03-04 |
| 2018-06-30 | $32.22M 6-K · filed 2018-08-30 |
| 2017-12-31 | $51.68M 20-F · filed 2019-02-26 |
| 2016-12-31 | $67.81M 20-F · filed 2018-02-22 |